Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the von Willebrand factor-cleaving protease

Citation
S. Fontana et al., Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the von Willebrand factor-cleaving protease, BR J HAEM, 113(1), 2001, pp. 100-102
Citations number
12
Categorie Soggetti
Hematology,"Cardiovascular & Hematology Research
Journal title
BRITISH JOURNAL OF HAEMATOLOGY
ISSN journal
00071048 → ACNP
Volume
113
Issue
1
Year of publication
2001
Pages
100 - 102
Database
ISI
SICI code
0007-1048(200104)113:1<100:MHAIMM>2.0.ZU;2-8
Abstract
Complete deficiency of von Willebrand factor-cleaving protease (VWF-cp) has recently been identified as a pathogenetically important factor for thromb otic thrombocytopenic purpura (TTP). Microangiopathic haemolytic anaemia (M AHA) with thrombocytopenia in patients with metastasizing neoplasms is clin ically similar to TTP, however, the pathogenesis of the condition is unclea r. Partial deficiency of VWF-cp in metastasizing malignancy has recently be en reported in patients without MAHA, Our study shows normal or subnormal V WF-cp activity in four patients with metastasizing neoplasia-associated MAH A but, in contrast to classical TTP, no complete deficiency of VWF-cp despi te the full clinical picture of MAHA.